WithdrawnNCT01272752
Anti-psychotic Medication (New Use) Weight Loss Study
Placebo comparisonAges 18+United StatesSchizophrenia
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- Sioux FallsSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateApril 2013
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- Avera McKennan Hospital & University Health Center
- Sponsor type
- University
- Study type
- Other
- Intervention type
- DIETARY_SUPPLEMENT
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT01272752
- Official title
Show the full official title
Surveillance Study of Weight Response and Body Composition in Subjects Who Are First-Time Users (Less Than 3 Months) of the Following Medications: Risperdal, Seroquel, and/or Zyprexa, in Combination With 500 mg IHBG-10 TID
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Sioux Falls
Questions about this study
Who is behind this study?
The study sponsor is Avera McKennan Hospital & University Health Center, a university.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
